Supplements & nutraceuticals
Nutraceutical Regulations in India: A Complete Guide for Supplement Brands
A supplement launch in India needs linked decisions on category, ingredients, dose, format, licensing, safety evidence, label and claims. FSSAI’s 2016 framework must be read alongside the operationalised 2022 provisions and later directions. An ordinary proprietary-food checklist is insufficient.
By the MyFoodLicense team Sources checked 6 min read
In this guide
- Read the operative framework together
- Choose the category from purpose and composition
- Establish ingredient identity and permission
- Calculate the dose on the correct basis
- Review format and manufacturing risks
- Resolve licensing and approvals separately
- Build the label and claim file
- Maintain the product after launch
- A worked example
- Your practical checklist
- Explore the detailed guides
- Frequently asked questions
- Official sources
Read the operative framework together
The official directory lists the 2016 Health Supplements and Nutraceuticals regulations and a direction dated 18 October 2022. That direction re-operationalises the 2022 provisions together with the specified May 2022 additions. Treat the framework as a set of regulations and directions, distinguishing their legal status and date. Read the October direction; read the operationalised provisions.
Older articles commonly use schedule numbers from the 2016 framework without explaining changes in the 2022 structure. Do not mix entries from different versions into a single undocumented permission list. The dossier should identify the actual provision relied on for each input and any later clarification.
Choose the category from purpose and composition
| Route | Central assessment question |
|---|---|
| Health supplement | Does it supplement the normal diet through the permitted nutritional or physiological substances? |
| Nutraceutical | Do the ingredients, purpose and presentation fit the relevant category conditions? |
| FSDU | Is it specially formulated for a particular dietary requirement rather than ordinary mass-consumption positioning? |
| FSMP | Is it intended for dietary management under medical supervision and does it satisfy the specialised requirements? |
| Prebiotic or probiotic food | Do the ingredients, organism identity, quantity and evidence meet the applicable provisions? |
These prompts do not replace the category definitions. A protein powder can have different questions depending on its intended audience and representations. A gummy is a delivery format, not an automatic regulatory category. Read the category comparison.
Establish ingredient identity and permission
Obtain complete specifications for nutrients, amino acids, botanicals, extracts, microbial preparations, carriers and additives. Check permitted sources, plant parts, forms, purity criteria and use conditions. A familiar botanical name does not prove permission for a concentrated extract. A foreign supplier’s legality statement is evidence to investigate, not the final Indian decision.
Keep a row for every ingredient showing identity, input quantity, daily exposure, applicable entry and restrictions. Document the scientific rationale for combinations. Where permission remains unresolved, assess approval or reformulation before commercial manufacture or import. Review botanicals and non-specified approval.
Calculate the dose on the correct basis
The operationalised provisions address specified nutrient levels and, where levels are not specified, the applicable ICMR RDA position. Category-specific exceptions and approval routes need their own reading. Do not apply a single blanket percentage to every product, nutrient and consumer group. Read the RDA direction.
Calculate active nutrient contribution rather than raw salt or premix weight, and sum all contributing inputs across the recommended daily usage. Check age group, serving frequency, units and stability evidence. A scoop amount and a daily dose are not necessarily identical. Read permitted forms and RDA calculations.
Review format and manufacturing risks
The 2022 provisions list permitted delivery forms with category-specific restrictions and conditions. Conventional-looking bars or candies need clear differentiation where they are regulated as supplements. Nano-derived ingredients and modified delivery formats create separate approval questions.
Define product specifications, process controls, packaging and stability criteria before scale-up. Hygroscopic powders, effervescent tablets, gummies and live microbial foods have different production and storage risks. Supplier certificates should be checked against the actual material and relevant test scope. Review format pitfalls; review prebiotic and probiotic foods.
Resolve licensing and approvals separately
The 2026 KoB table specifies Central licensing for listed health-supplement and nutraceutical manufacturing irrespective of turnover. Map the manufacturer, brand-owner arrangement, importer and premises as applicable. The factory’s authorisation does not automatically settle the brand’s role. Read specialised manufacturing rows.
The May 2026 ePAAS order includes specified product, ingredient, claim, FSMP and other approval or notification routes. Submission is through the current system from 1 June 2026. A filed application, safety dossier or general food licence does not replace a required approval decision. Read current approval routing.
Build the label and claim file
Apply general food-labelling rules alongside category statements, recommended usage and relevant warnings. Not-for-medicinal-use wording has specific scope and exceptions; do not print a universal warning panel without checking the category. Review supplement declarations.
Claims should fit the product, dose, audience and evidence. Disease-treatment representations cannot be repaired by a conflicting disclaimer. Keep scientific substantiation and any required approval or notification with the exact approved sentence. Labels, marketplace listings and influencer campaigns should use controlled wording. Read supplement claims.
Maintain the product after launch
Set up supplier, batch, testing, traceability, complaint and applicable-return records. Monitor changes in ingredient source, extract specification, dose and claims. A supplier substitution can reopen the permission assessment even when the front label looks unchanged.
Keep one product dossier connecting the classification, formula, evidence, approvals, certificates and artwork. Assign an owner for regulatory updates and ensure the contract manufacturer can provide the records needed for a complaint or recall. Read post-licence compliance and private-label responsibilities.
A worked example
Hypothetical example
A brand plans an adult vitamin gummy and receives a ready-made label from a contract factory. It first establishes the category, daily dosage, nutrient forms and excipient permissions. It then reviews manufacturing authorisations, relevant evidence and warning placement. The factory template becomes a design input after those decisions, rather than the basis for declaring the product compliant.
Your practical checklist
- Record category, purpose, audience and daily dose.
- Reconcile regulations, directions and schedule versions.
- Establish every ingredient and additive permission.
- Calculate active nutrient contribution and conditions.
- Review format, process, packaging and stability.
- Resolve licensing and applicable approvals.
- Prepare category-specific label and claim evidence.
- Maintain supplier, batch, testing and change records.
Download this preparation checklist
For help applying this review to your business, explore our End-to-End Product Compliance service. Bring the documents described above so the consultation can focus on the decisions still unresolved.
Explore the detailed guides
Use these focused articles to work through the decisions relevant to your business.
- Health Supplement vs Nutraceutical vs FSDU vs FSMP: Which Category Is Your Product?
- How to Launch a Protein Powder Brand in India: Regulatory Checklist
- FSSAI or AYUSH? Herbal and Ayurvedic Products Explained
- Vitamins and Minerals in Supplements: RDA Limits and Permitted Forms
- Gummies, Effervescents and Novel Formats: Regulatory Pitfalls
- Probiotics and Prebiotics: Permitted Strains and Claims
- Botanicals in Nutraceuticals: How to Check if a Plant Ingredient Is Permitted
- Labelling a Health Supplement: Mandatory Warnings and Declarations
- Claims for Supplements: What's Allowed
Frequently asked questions
Are the 2016 regulations the only source?
No. Read them alongside the operationalised 2022 provisions and later directions.
Are all supplements proprietary foods?
No. The proprietary definition excludes relevant specialised categories.
Does a gummy determine the category?
No. Format, purpose, composition, audience and presentation must be assessed together.
Do supplement manufacturers use ordinary registration bands?
The current table specifies Central licensing for the listed specialised manufacturing activities.
Can the manufacturer approve every claim?
Claims need the applicable evidence and regulatory route; a production agreement does not replace them.
Official sources and further reading
Checked on 2 October 2026. Gazette notifications and operative directions prevail over compilations and summaries, including this guide.
- Direction dated 18 October 2022, uploaded 28 November 2022: Operationalisation of 2022 provisions and May 2022 additions; distinguish directions from final Gazette regulations.
- Operationalised supplement provisions, 29 March 2022 direction: Definitions, schedules, dosage, category-specific warnings and product requirements; read with later directions.
- 2016 supplement regulations: compendium 29 September 2021: Historical base framework; not used alone to establish current operative provisions.
- FSSAI RDA 2020 compliance direction, July 2023: Age and nutrient reference tables; distinguish nutritional content from raw compound mass.
- FoSCoS revised Kind-of-Business eligibility table, 2 April 2026 file: Activity-specific eligibility and annual fees. The PDF itself is marked updated 1 April 2026; relevant rows appear on pages 3, 6, 7 and 9.
- FSSAI order of 6 May 2026: ePAAS single-window approvals: Exclusive ePAAS submission from 1 June 2026 for specified approval and notification routes.
- Advertising and Claims Regulations compendium, Version IV, 14 December 2022: Nutrition-claim thresholds and general claim conditions. Protein uses RDA-based alternatives, not a universal percentage-of-energy rule.
This guide is general information, not legal advice; the right route depends on your product and business facts. Examples marked hypothetical are illustrations, not client cases. MyFoodLicense is an independent consultancy and is not affiliated with FSSAI; applications are decided by the competent authority on the official FoSCoS portal.